Clincosm LogoSign in Get a demo

Hematologic Malignancies

Showing NaN - NaN of 12
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematologic Malignancies Trial in Australia, United States (APG-2575)

Recruiting
  • Hematologic Malignancies
  • Jacksonville, Florida
  • +4 more
Aug 12, 2022

Hematologic Malignancies, Inborn Errors of Metabolism Disorders, Immune Deficiencies Trial in Durham (CliniMACS CD34 Reagent

Available
  • Hematologic Malignancies
  • +2 more
  • CliniMACS CD34 Reagent System
  • Durham, North Carolina
    Duke University Medical Center
Nov 12, 2021

Hematologic Malignancies Trial in Durham (Home Care)

Completed
  • Hematologic Malignancies
  • Home Care
  • Durham, North Carolina
    Duke University Medical Center
Jul 15, 2019

Solid Tumor, Hematologic Malignancies Trial in United States (BGJ398)

Terminated
Has Results
  • Solid Tumor
  • Hematologic Malignancies
  • Birmingham, Alabama
  • +55 more
May 28, 2019

Solid Tumors, Hematologic Malignancies, Hepatic Impairment Trial in Worldwide (Carfilzomib)

Completed
Has Results
  • Solid Tumors
  • +2 more
  • Detroit, Michigan
  • +10 more
Apr 28, 2017

Cancer, Chronic Lymphocytic Leukemia, Diffuse Large Cell Lymphoma Trial in Hackensack, Durham, Salt Lake City (AMG 319)

Completed
  • Cancer
  • +13 more
  • AMG 319
  • Hackensack, New Jersey
  • +2 more
Feb 8, 2017

Hematologic Malignancies Trial in Durham (ceritinib)

Withdrawn
  • Hematologic Malignancies
  • Durham, North Carolina
    Duke University Medical Center
Jan 30, 2017

Hematologic Malignancies, Leukemia, MDS Trial in United States (ridaforolimus)

Completed
  • Hematologic Malignancies
  • +4 more
  • Chicago, Illinois
  • +7 more
Aug 18, 2015

Cord Blood Stem Cell Transplantation, Hematologic Malignancies Trial in United States (Cord blood transplantation)

Completed
  • Cord Blood Stem Cell Transplantation
  • Hematologic Malignancies
  • Cord blood transplantation
  • Duarte, California
  • +9 more
Mar 7, 2014

Hematologic Malignancies Trial in Duluth, Durham (CAMPATH (alemtuzumab))

Terminated
  • Hematologic Malignancies
  • CAMPATH (alemtuzumab)
  • Duluth, Minnesota
  • +1 more
Feb 4, 2014

Hematologic Malignancies, AML Trial in Worldwide (CP-4055)

Completed
  • Hematologic Malignancies
  • AML
  • Valhalla, New York
  • +15 more
Sep 12, 2013

Hematologic Malignancies Trial in Durham (Non-neutropenic Diet)

Completed
  • Hematologic Malignancies
  • Non-neutropenic Diet
  • Durham, North Carolina
    Duke University Medical Center
May 8, 2013